Getting plant toxins to fuse

Leukemia Research

Volumn 21, Issue 10, 1997, Pages 997-999

  Kreitman, Robert J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CYTOKINE RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; PLANT TOXIN; PSEUDOMONAS EXOTOXIN; RICIN;

CYTOPLASM; CYTOTOXICITY; DRUG TARGETING; HUMAN; LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030830611     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00083-0     Document Type: Article

References (24)

1. Perentesis, J. P., Waddick, K. G., Bendel, A. E., Shao, Y., Warman, B. E., Chandan-Langlie, M. and Uckun, F. M., Induction of apoptosis in multidrug-resistant and radiation-resistant acute myeloid leukemia cells by a recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor receptor. Clinical Cancer Research, 1997, 3, 347.
2. Kreitman, R. J. and Pastan, I., Recombinant toxins containing human GM-CSF and either Pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells. Blood, 1997, 90, 252.
3. Endo, Y., Mitsui, K., Motizuki, M. and Tsurugi, K., The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. Journal of Biological Chemistry, 1987, 262, 5908.
4. Zamboni, M., Brigotti, M., Rambelli, F., Montanaro, L. and Sperti, S., High pressure liquid Chromatographic and fluorimetric methods for the determination of adenine released from ribosomes by ricin and gelonin. Biochemistry Journal, 1989, 259, 639.
5. Iglewski, B. H., Liu, P. V. and Kabat, D., Mechanism of action of Pseudomonas earuginosa exotoxin A: adenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo. Infection Immunity, 1977, 15, 138.
6. Van Ness, B. G., Howard, J. B. and Bodley, J. W., ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products. Journal of Biological Chemistry, 1980, 255, 10717.
7. Phan, L. D., Perentesis, J. P. and Bodley, J. W., Saccharomyces cerevisiae elongation factor 2. Mutagenesis of the histidine precursor of diphthamide yields a functional protein that is resistant to diphtheria toxin. Journal of Biological Chemistry, 1993, 268, 8665.
8. 280 generates the enzymatically active fragment which translocates to the cytosol. Journal of Biological Chemistry, 1992, 267, 25396.
9. 194. Journal of Biological Chemistry, 1990, 265, 20673.
10. Prior, T. I., FitzGerald, D. J. and Pastan, I., Barnase toxin: a new chimeric toxin composed of Pseudomonas exotoxin A and barnase. Cell, 1991, 64, 1017.
11. Kreitman, R. J., Chaudhary, V. K., Siegall, C. B., FitzGerald, D. J. and Pastan, I., Rational design of a chimeric toxin: an intramolecular location for the insertion of transforming growth factor a within Pseudomonas exotoxin as a targeting ligand. Bioconjugate Chemistry, 1992, 3, 58.
12. O'Hare, M., Brown, A. N., Hussain, K., Gebhardt, A., Watson, G., Roberts, L. M., Vitetta. E. S., Thorpe, P. E. and Lord, J. M., Cytotoxicity of a recombinant ricin-A-chain fusion protein containing a proteolytically-cleavable spacer sequence. FEBS Letters, 1990, 273, 200.
13. Cook. J. P., Savage, P. M., Lord, J. M. and Roberts, L. M., Biologically active interleukin-2-ricin A chain fusion proteins may require intracellular proteolytic cleavage to exhibit a cytotoxic effect. Bioconjugate Chemistry:, 1993, 4, 440.
14. Dore, J. M., Gras, E. and Wijdenes, J., Expression and activity of a recombinant chimeric protein composed of poke weed antiviral protein and of human interleukin-2. FEBS Letters, 1997, 402, 50.
15. Lappi, D. A., Ying, W., Barthelemy, I., Martineau, D., Prieto, I., Benatti, L., Soria, M. and Baird, A., Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein. Journal of Biological Chemistry, 1994, 269, 12552.
16. Better, M., Bernhard, S. L., Williams, R. E., Leigh, S. D., Bauer, R. J., Kung, A. H., Carroll, S. F. and Fishwild, D. M., T cell-targeted immunofusion proteins from Escherichia coli. Journal of Biological Chemistry, 1995, 270, 14951.
17. Kreitman, R. J., Chang, C. N., Hudson, D. V., Queen. C., Bailon. P. and Pastan, I., Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model. International Journal of Cancer, 1994, 57, 856.
18. Reiter, Y., Brinkmann, U., Kreitman, R. J., Jung, S.-H., Lee, B. and Pastan, I., Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions. Biochemistry, 1994, 33, 5451.
19. Spooner, R. A., Allen, D. J., Epenetos, A. A. and Lord, J. M., Expression of immunoglobulin heavy chain-ricin A chain fusions in mammalian cells. Molecular Immunology, 1994, 31, 117.
20. Frankel, A., Tagge, E., Chandler, J., Burbage, C., Hancock, G., Vesely, J. and Willingham, M., IL2-ricin fusion toxin is selectively cytotoxic in vitro to IL2 receptor-bearing tumor cells. Bioconjugate Chemistry, 1995, 6, 666.
21. Frankel, A. E., Burbage, C., Fu, T., Tagge, E., Chandler, J. and Willingham, M. C., Ricin toxin contains at least three galactose-binding sites located in B chain subdomains 1 alpha, 1 beta, and 2 gamma. Biochemistry;, 1996, 35, 14749.
22. Frankel, A., Tagge, E., Chandler. J., Burbage, C. and Willingham, M., Double-site ricin B chain mutants retain galactose binding. Protein Engineering, 1996, 9, 371.
23. Frankel, A., Tagge, E., Chandler, J., Burbage, C., Hancock, G., Vesely, J. and Willingham, M., Characterization of single site ricin toxin B chain mutants. Bioconjugate Chemistry, 1996, 7, 30.
24. Frankel, A. E., Burbage, C., Fu, T., Tagge, E., Chandler, J. and Willingham, M., Characterization of a ricin fusion toxin targeted to the interleukin-2 receptor. Protein Engineering, 1996, 9, 913.